Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial

Muhammad I Husain,1 Imran B Chaudhry,2 Munir M Hamirani,3 Fareed A Minhas,4 Ajmal Kazmi,5 John Hodsoll,6 Peter M Haddad,7 John FW Deakin,7 Nusrat Husain,7 Allan H Young8 1Camden and Islington NHS Foundation Trust, St Pancras Hospital, London, UK; 2Pakistan Institute of Learning and Living, 3Departm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Husain MI, Chaudhry IB, Hamirani MM, Minhas FA, Kazmi A, Hodsoll J, Haddad P, Deakin JFW, Husain N, Young AH
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Bipolar Disorder Depression Inflammation Anti-Inflammatory Minocycline Celecoxib Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/7f41693afeb649b795e15dbcc46168a3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7f41693afeb649b795e15dbcc46168a3
record_format	dspace
spelling	oai:doaj.org-article:7f41693afeb649b795e15dbcc46168a32021-12-02T06:59:40ZMinocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial1178-2021https://doaj.org/article/7f41693afeb649b795e15dbcc46168a32016-12-01T00:00:00Zhttps://www.dovepress.com/minocycline-and-celecoxib-as-adjunctive-treatments-for-bipolar-depress-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Muhammad I Husain,1 Imran B Chaudhry,2 Munir M Hamirani,3 Fareed A Minhas,4 Ajmal Kazmi,5 John Hodsoll,6 Peter M Haddad,7 John FW Deakin,7 Nusrat Husain,7 Allan H Young8 1Camden and Islington NHS Foundation Trust, St Pancras Hospital, London, UK; 2Pakistan Institute of Learning and Living, 3Department of Psychiatry, Abbasi Shaheed Hospital, Karachi, 4Institute of Psychiatry, Rawalpindi Medical College, Rawalpindi, 5Department of Psychiatry, Karwan-e-Hayat Hospital, Karachi, Pakistan; 6Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London; 7Division of Psychology and Mental Health, University of Manchester, Manchester, 8Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK Background: Evidence suggests that the use of anti-inflammatory agents may improve depressive symptoms in patients with bipolar affective disorder. However, there are few well-designed clinical trials demonstrating the efficacy of these newer treatment strategies.Patients and methods: This is a multicenter, 3-month, randomized, placebo-controlled, double-blind, factorial design trial of minocycline and/or celecoxib added to TAU for the treatment of depressive symptoms in patients experiencing a DSM-5 bipolar I or II disorder and a current major depressive episode. A total of 240 participants will undergo screening and randomization followed by four assessment visits. The primary outcome measure will be mean change from baseline to week 12 on the Hamilton Depression Scale scores. Clinical assessments using the Clinical Global Impression scale, Patient Health Questionnaire-9, and the Generalized Anxiety Disorder 7-item scale will be carried out at every visit as secondary outcomes. Side-effect checklists will be used to monitor the adverse events at each visit. Complete blood count and plasma C-reactive protein will be measured at baseline and at the end of the treatment. Minocycline will be started at 100 mg once daily and increased to 200 mg at 2 weeks. Celecoxib will be started at 200 mg once daily and increased to 400 mg at 2 weeks.Discussion: Anti-inflammatory agents have been shown to be potentially efficacious in the treatment of depressive symptoms. The aim of this study is to determine whether the addition of minocycline and/or celecoxib to TAU improves depressive symptoms in patients with bipolar affective disorder. Keywords: bipolar disorder, depression, inflammation, anti-inflammatory, minocycline, celecoxibHusain MIChaudhry IBHamirani MMMinhas FAKazmi AHodsoll JHaddad PDeakin JFWHusain NYoung AHDove Medical PressarticleBipolar DisorderDepressionInflammationAnti-InflammatoryMinocyclineCelecoxibNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 1-8 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Bipolar Disorder Depression Inflammation Anti-Inflammatory Minocycline Celecoxib Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Bipolar Disorder Depression Inflammation Anti-Inflammatory Minocycline Celecoxib Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Husain MI Chaudhry IB Hamirani MM Minhas FA Kazmi A Hodsoll J Haddad P Deakin JFW Husain N Young AH Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
description	Muhammad I Husain,1 Imran B Chaudhry,2 Munir M Hamirani,3 Fareed A Minhas,4 Ajmal Kazmi,5 John Hodsoll,6 Peter M Haddad,7 John FW Deakin,7 Nusrat Husain,7 Allan H Young8 1Camden and Islington NHS Foundation Trust, St Pancras Hospital, London, UK; 2Pakistan Institute of Learning and Living, 3Department of Psychiatry, Abbasi Shaheed Hospital, Karachi, 4Institute of Psychiatry, Rawalpindi Medical College, Rawalpindi, 5Department of Psychiatry, Karwan-e-Hayat Hospital, Karachi, Pakistan; 6Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London; 7Division of Psychology and Mental Health, University of Manchester, Manchester, 8Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK Background: Evidence suggests that the use of anti-inflammatory agents may improve depressive symptoms in patients with bipolar affective disorder. However, there are few well-designed clinical trials demonstrating the efficacy of these newer treatment strategies.Patients and methods: This is a multicenter, 3-month, randomized, placebo-controlled, double-blind, factorial design trial of minocycline and/or celecoxib added to TAU for the treatment of depressive symptoms in patients experiencing a DSM-5 bipolar I or II disorder and a current major depressive episode. A total of 240 participants will undergo screening and randomization followed by four assessment visits. The primary outcome measure will be mean change from baseline to week 12 on the Hamilton Depression Scale scores. Clinical assessments using the Clinical Global Impression scale, Patient Health Questionnaire-9, and the Generalized Anxiety Disorder 7-item scale will be carried out at every visit as secondary outcomes. Side-effect checklists will be used to monitor the adverse events at each visit. Complete blood count and plasma C-reactive protein will be measured at baseline and at the end of the treatment. Minocycline will be started at 100 mg once daily and increased to 200 mg at 2 weeks. Celecoxib will be started at 200 mg once daily and increased to 400 mg at 2 weeks.Discussion: Anti-inflammatory agents have been shown to be potentially efficacious in the treatment of depressive symptoms. The aim of this study is to determine whether the addition of minocycline and/or celecoxib to TAU improves depressive symptoms in patients with bipolar affective disorder. Keywords: bipolar disorder, depression, inflammation, anti-inflammatory, minocycline, celecoxib
format	article
author	Husain MI Chaudhry IB Hamirani MM Minhas FA Kazmi A Hodsoll J Haddad P Deakin JFW Husain N Young AH
author_facet	Husain MI Chaudhry IB Hamirani MM Minhas FA Kazmi A Hodsoll J Haddad P Deakin JFW Husain N Young AH
author_sort	Husain MI
title	Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
title_short	Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
title_full	Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
title_fullStr	Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
title_full_unstemmed	Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
title_sort	minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/7f41693afeb649b795e15dbcc46168a3
work_keys_str_mv	AT husainmi minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial AT chaudhryib minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial AT hamiranimm minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial AT minhasfa minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial AT kazmia minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial AT hodsollj minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial AT haddadp minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial AT deakinjfw minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial AT husainn minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial AT youngah minocyclineandcelecoxibasadjunctivetreatmentsforbipolardepressionastudyprotocolforamulticenterfactorialdesignrandomizedcontrolledtrial
_version_	1718399643245608960

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial

Ejemplares similares